Mulberry Biotherapeutics is developing novel targeted bacteria-mediated therapy for patients with NF2 and other non-cancerous neoplasms. The company focused on delivering transformative improvements in the health and quality of life to individuals affected by the rare genetic disorder neurofibromato... Read more
This company has no teams yet